Experiment: 6DRG

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-15N13C] hFABP1 wild type, 0.5 mM GW7647, 20 mM sodium phosphate, 50 mM sodium chloride, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 800
2	2D 1H-13C HSQC	0.5 mM [U-15N13C] hFABP1 wild type, 0.5 mM GW7647, 20 mM sodium phosphate, 50 mM sodium chloride, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 800
3	3D 15N-resolved [1H,1H]-NOESY	0.5 mM [U-15N13C] hFABP1 wild type, 0.5 mM GW7647, 20 mM sodium phosphate, 50 mM sodium chloride, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 800
4	3D 13Cali resolved [1H,1H]-NOESY	0.5 mM [U-15N13C] hFABP1 wild type, 0.5 mM GW7647, 20 mM sodium phosphate, 50 mM sodium chloride, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 800
5	3D 13Caro resolved [1H,1H]-NOESY	0.5 mM [U-15N13C] hFABP1 wild type, 0.5 mM GW7647, 20 mM sodium phosphate, 50 mM sodium chloride, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 800
6	2D F1-edited, F2-13C,15N-filtered [1H,1H] NOESY	0.5 mM [U-15N13C] hFABP1 wild type, 0.5 mM GW7647, 20 mM sodium phosphate, 50 mM sodium chloride, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 800
7	3D F1-13C,15N-filtered, F2-13Cali edited [1H,1H] NOESY	0.5 mM [U-15N13C] hFABP1 wild type, 0.5 mM GW7647, 20 mM sodium phosphate, 50 mM sodium chloride, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 800
8	2D 1H-15N HSQC	1 mM [U-2H,15N13C] hFABP1 wild type, 1 mM GW7647, 50 mM sodium chloride, 20 mM sodium phosphate, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 600
9	2D F1, F2-13C,15N-filtered [1H,1H] NOESY	1 mM [U-2H,15N13C] hFABP1 wild type, 1 mM GW7647, 50 mM sodium chloride, 20 mM sodium phosphate, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 600
10	2D F1-edited, F2-13C,15N-filtered [1H,1H] NOESY	1 mM [U-2H,15N13C] hFABP1 wild type, 1 mM GW7647, 50 mM sodium chloride, 20 mM sodium phosphate, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 600
11	3D F1-13C,15N-filtered, F2-15N edited [1H,1H] NOESY	1 mM [U-2H,15N13C] hFABP1 wild type, 1 mM GW7647, 50 mM sodium chloride, 20 mM sodium phosphate, 1 % D6 DMSO	90% H2O/10% D2O	20 mM sodium phosphate and 50 mM NaCl mM	5.5	1 atm	308	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
restraint energy minimization	OPALp	OPALp

NMR Ensemble Information
Conformer Selection Criteria	structures with acceptable covalent geometry
Conformers Calculated Total Number	40
Conformers Submitted Total Number	10
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	TopSpin		Bruker Biospin
3	chemical shift assignment	CARA		Keller and Wuthrich
4	peak picking	CARA		Keller and Wuthrich
5	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
6	refinement	Prime		Prime, Schrodinger, LLC, New York, NY, 2018
7	refinement	OPALp		Koradi et al, 2000

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.